SCHEMBL30835995

SCHEMBL30835995

CC(C)(C)OC(=O)N1CC(C#N)(C=Cc2cc(C(F)(F)F)on2)C1

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 2/20 0.35
▸ USP30 Q70CQ3 1/20 0.35
▸ SCD5 Q86SK9 1/20 0.34
▸ EGLN2 Q96KS0 1/20 0.34
▸ JAK1 P23458 6/20 0.33
▸ JAK2 O60674 5/20 0.33
▸ GPR119 Q8TDV5 4/20 0.33
▸ F2R P25116 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ STS P08842 1/20 0.32
▸ F13A1 P00488 1/20 0.32
▸ TGM2 P21980 1/20 0.32
▸ TGM1 P22735 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30835897 0.85 HDAC4 (0.37) HDAC4USP30SCD5GPR119STS
SCHEMBL30835908 0.85 USP30 (0.38) HDAC4USP30SCD5GPR119STS
SCHEMBL27401664 0.85 HDAC4 (0.37) HDAC4USP30SCD5GPR119STS
SCHEMBL30835929 0.82 CNR1 (0.31) —
SCHEMBL27399663 0.82 CNR1 (0.31) —
SCHEMBL30835987 0.78 SCD5 (0.38) HDAC4USP30SCD5GPR119STS
SCHEMBL30835823 0.77 SCD5 (0.40) HDAC4USP30SCD5GPR119F2R
SCHEMBL31556570 0.76 HDAC4 (0.38) HDAC4USP30GPR119MTORSTS
SCHEMBL30835842 0.76 MAPT (0.43) JAK1JAK2GPR119
SCHEMBL27401990 0.76 HDAC4 (0.38) HDAC4USP30GPR119MTORSTS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587424-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS Bridgene Biosciences, Inc. (US) 2025-07-23 — — EP disclosed
CN-119894866-A YAP/TAZ-TEAD oncoprotein inhibitors 布里奇恩生物科学公司 2025-04-25 — — CN disclosed
WO-2024059317-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS BRIDGENE BIOSCIENCES, INC. (US) 2024-03-21 — — WO disclosed
Send feedback